Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses

Area of Science:

• Immunology and Molecular Biology
• Protein Engineering and Computational Design

Background:

• Cytokines are crucial for T lymphocyte differentiation and immune response specialization.
• Suppressor of Cytokine Signaling (SOCS) proteins regulate cytokine signaling but often lack specificity.
• SOCS3 inhibits both IL-12 and IL-2 signaling pathways, limiting therapeutic applications.

Purpose of the Study:

• To engineer a mutant SOCS3 protein with altered specificity to selectively inhibit JAK2-dependent cytokine signaling while sparing JAK1-dependent pathways.
• To investigate the impact of this engineered SOCS3 on T cell differentiation and function in vitro and in vivo.

Main Methods:

• Computational protein design utilizing SOCS3 and JAK crystal structures.
• Generation and characterization of a mutant SOCS3 designed to interact with JAK2 but not JAK1.
• Expression of wild-type and mutant SOCS3 in CD8 T cells and assessment of STAT phosphorylation, T cell expansion, and differentiation phenotypes in vitro and in vivo.

Main Results:

• The engineered mutant SOCS3 selectively inhibited JAK2-dependent STAT4 phosphorylation induced by IL-12.
• The mutant SOCS3 failed to inhibit STAT phosphorylation induced by JAK1-dependent cytokines (IL-2, IFN-α, IL-21), unlike wild-type SOCS3.
• Expression of mutant SOCS3 restored CD8 T cell expansion in vivo and promoted effector T cell differentiation, reversing the effects of wild-type SOCS3.

Conclusions:

• SOCS proteins can be engineered for fine-tuned specificity, enabling precise control over cytokine signaling pathways.
• Targeted manipulation of SOCS3 specificity significantly impacts T cell biology, including expansion and differentiation.
• Engineered SOCS proteins represent a promising strategy for programming T cell differentiation for therapeutic benefit.